LENZ LENZ Therapeutics, Inc.
$3.18▲ +0.95%
Healthcare
Other
Volume 224.8K
Avg Volume (10D) 708.2K
Key Metrics & Fundamentals
Market Cap
$99.92M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.06 - 32.13
% vs 50 MA
-24.30%
% vs 200 MA
-61.70%
RSI-14
31.9
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.35
Free Cash Flow
-$38.73M
Gross Rev
$5.49M
Gross Profit
$5.21M
EBITDA
-$34.06M
COGS
$280,000
Operating Exp
$39.38M
Operating Income
-$34.17M
EBIT
-$34.17M
Pretax Income
-$31.92M
Net Income
-$31.92M
EPS (Diluted)
-1.02
Price & Volume History
Loading chart…
Recent News
Regeneron (REGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks · Oct 23, 2026 9:00 AM ET
LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
GlobeNewswire · Oct 22, 2026 8:00 AM ET
LENZ Therapeutics (LENZ) Stock Fair Value Falls After Analysts Cut VIZZ Launch Expectations
Simply Wall St. · Oct 21, 2026 12:27 AM ET
LENZ Therapeutics (LENZ) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 19, 2026 9:55 AM ET
LENZ Therapeutics (LENZ) Stock Sees Fair Value Moves Lower After Analyst Target Cuts
Simply Wall St. · Aug 14, 2026 9:12 PM ET
LENZ Therapeutics Inc (LENZ) (Q2 2026) Earnings Call Highlights: VIZZ Launch Momentum ...
GuruFocus.com · Aug 12, 2026 1:02 AM ET
LENZ Therapeutics, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 11, 2026 10:39 PM ET
LENZ Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 11, 2026 7:04 PM ET
LENZ Therapeutics, Inc. (LENZ) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 11, 2026 5:25 PM ET
LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire · Aug 11, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See LENZ's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.